vs

Side-by-side financial comparison of ARTESIAN RESOURCES CORP (ARTNA) and Zymeworks Inc. (ZYME). Click either name above to swap in a different company.

ARTESIAN RESOURCES CORP is the larger business by last-quarter revenue ($28.0M vs $27.6M, roughly 1.0× Zymeworks Inc.). ARTESIAN RESOURCES CORP runs the higher net margin — 14.8% vs -71.0%, a 85.7% gap on every dollar of revenue. On growth, Zymeworks Inc. posted the faster year-over-year revenue change (72.6% vs 4.3%). ARTESIAN RESOURCES CORP produced more free cash flow last quarter ($-7.9M vs $-31.8M).

Artesian Resources Corp is a US-headquartered regulated water utility and wastewater service provider, primarily serving residential, commercial, industrial and municipal customers across Delaware. It focuses on delivering safe, reliable drinking water supply and sustainable wastewater treatment solutions to local communities.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital th...

ARTNA vs ZYME — Head-to-Head

Bigger by revenue
ARTNA
ARTNA
1.0× larger
ARTNA
$28.0M
$27.6M
ZYME
Growing faster (revenue YoY)
ZYME
ZYME
+68.2% gap
ZYME
72.6%
4.3%
ARTNA
Higher net margin
ARTNA
ARTNA
85.7% more per $
ARTNA
14.8%
-71.0%
ZYME
More free cash flow
ARTNA
ARTNA
$24.0M more FCF
ARTNA
$-7.9M
$-31.8M
ZYME

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ARTNA
ARTNA
ZYME
ZYME
Revenue
$28.0M
$27.6M
Net Profit
$4.1M
$-19.6M
Gross Margin
Operating Margin
20.6%
-80.1%
Net Margin
14.8%
-71.0%
Revenue YoY
4.3%
72.6%
Net Profit YoY
7.5%
34.3%
EPS (diluted)
$0.39
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$28.0M
Q3 25
$30.5M
$27.6M
Q2 25
$28.5M
$48.7M
Q1 25
$25.9M
$27.1M
Q4 24
$26.9M
$31.0M
Q3 24
$29.1M
$16.0M
Q2 24
$27.4M
$19.2M
Q1 24
$24.5M
$10.0M
Net Profit
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$4.1M
Q3 25
$7.0M
$-19.6M
Q2 25
$6.3M
$2.3M
Q1 25
$5.4M
$-22.6M
Q4 24
$3.8M
$-23.5M
Q3 24
$6.8M
$-29.9M
Q2 24
$5.3M
$-37.7M
Q1 24
$4.4M
$-31.7M
Operating Margin
ARTNA
ARTNA
ZYME
ZYME
Q4 25
20.6%
Q3 25
28.3%
-80.1%
Q2 25
27.5%
-1.4%
Q1 25
21.4%
-94.5%
Q4 24
21.0%
-71.6%
Q3 24
29.5%
-213.8%
Q2 24
26.3%
-222.9%
Q1 24
19.2%
-376.9%
Net Margin
ARTNA
ARTNA
ZYME
ZYME
Q4 25
14.8%
Q3 25
22.8%
-71.0%
Q2 25
22.0%
4.8%
Q1 25
21.0%
-83.5%
Q4 24
14.3%
-75.8%
Q3 24
23.4%
-186.6%
Q2 24
19.4%
-195.8%
Q1 24
18.0%
-315.6%
EPS (diluted)
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$0.39
Q3 25
$0.68
$-0.26
Q2 25
$0.61
$0.03
Q1 25
$0.53
$-0.30
Q4 24
$0.37
$-0.32
Q3 24
$0.66
$-0.39
Q2 24
$0.52
$-0.49
Q1 24
$0.43
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARTNA
ARTNA
ZYME
ZYME
Cash + ST InvestmentsLiquidity on hand
$52.0K
$64.8M
Total DebtLower is stronger
$176.4M
Stockholders' EquityBook value
$249.9M
$320.1M
Total Assets
$851.2M
$397.3M
Debt / EquityLower = less leverage
0.71×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$52.0K
Q3 25
$705.0K
$64.8M
Q2 25
$349.0K
$98.3M
Q1 25
$3.7M
$76.2M
Q4 24
$1.1M
$66.1M
Q3 24
$10.7M
$122.4M
Q2 24
$6.3M
$71.0M
Q1 24
$9.5M
$114.8M
Total Debt
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$176.4M
Q3 25
Q2 25
Q1 25
Q4 24
$178.7M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$249.9M
Q3 25
$248.8M
$320.1M
Q2 25
$244.9M
$334.5M
Q1 25
$241.7M
$325.0M
Q4 24
$239.2M
$338.8M
Q3 24
$238.3M
$367.0M
Q2 24
$234.4M
$406.2M
Q1 24
$232.0M
$438.0M
Total Assets
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$851.2M
Q3 25
$833.9M
$397.3M
Q2 25
$819.3M
$408.4M
Q1 25
$808.9M
$425.5M
Q4 24
$798.6M
$463.1M
Q3 24
$796.0M
$487.2M
Q2 24
$783.1M
$515.6M
Q1 24
$798.6M
$553.8M
Debt / Equity
ARTNA
ARTNA
ZYME
ZYME
Q4 25
0.71×
Q3 25
Q2 25
Q1 25
Q4 24
0.75×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARTNA
ARTNA
ZYME
ZYME
Operating Cash FlowLast quarter
$10.5M
$-31.4M
Free Cash FlowOCF − Capex
$-7.9M
$-31.8M
FCF MarginFCF / Revenue
-28.1%
-115.2%
Capex IntensityCapex / Revenue
65.4%
1.5%
Cash ConversionOCF / Net Profit
2.53×
TTM Free Cash FlowTrailing 4 quarters
$-18.5M
$-65.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$10.5M
Q3 25
$11.0M
$-31.4M
Q2 25
$7.9M
$12.1M
Q1 25
$11.0M
$-3.4M
Q4 24
$6.7M
$-41.5M
Q3 24
$10.7M
$-5.9M
Q2 24
$6.9M
$-25.0M
Q1 24
$12.6M
$-37.7M
Free Cash Flow
ARTNA
ARTNA
ZYME
ZYME
Q4 25
$-7.9M
Q3 25
$-3.3M
$-31.8M
Q2 25
$-7.9M
$11.6M
Q1 25
$560.0K
$-3.4M
Q4 24
$-8.3M
$-41.8M
Q3 24
$-1.9M
$-6.8M
Q2 24
$-2.6M
$-25.6M
Q1 24
$3.7M
$-37.9M
FCF Margin
ARTNA
ARTNA
ZYME
ZYME
Q4 25
-28.1%
Q3 25
-10.7%
-115.2%
Q2 25
-27.8%
23.7%
Q1 25
2.2%
-12.6%
Q4 24
-30.9%
-134.8%
Q3 24
-6.5%
-42.4%
Q2 24
-9.4%
-133.0%
Q1 24
15.0%
-377.5%
Capex Intensity
ARTNA
ARTNA
ZYME
ZYME
Q4 25
65.4%
Q3 25
46.7%
1.5%
Q2 25
55.6%
1.1%
Q1 25
40.2%
0.1%
Q4 24
55.9%
1.0%
Q3 24
43.1%
5.6%
Q2 24
34.5%
3.1%
Q1 24
36.4%
1.8%
Cash Conversion
ARTNA
ARTNA
ZYME
ZYME
Q4 25
2.53×
Q3 25
1.58×
Q2 25
1.26×
5.21×
Q1 25
2.02×
Q4 24
1.74×
Q3 24
1.56×
Q2 24
1.29×
Q1 24
2.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARTNA
ARTNA

Water Sales$22.3M80%
Other Utility Operating Revenue$3.8M14%
Non Utility Operating Revenue$1.9M7%

ZYME
ZYME

Segment breakdown not available.

Related Comparisons